Literature DB >> 15534279

Acute neuropathy with multiple conduction blocks after TNFalpha monoclonal antibody therapy.

Oliver C Singer1, Bettina Otto, Helmuth Steinmetz, Ulf Ziemann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15534279     DOI： 10.1212/01.wnl.0000142974.81103.95

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  18 in total

1.  Isolated motor conduction block associated with infliximab.

Authors:  A W Michell; A Gaitatzis; J Burge; M M Reilly; R Kapoor; M Koltzenburg
Journal:  J Neurol       Date:  2012-02-18       Impact factor: 4.849

Review 2.  Anti-inflammatory treatment of uveitis with biologicals: new treatment options that reflect pathogenetic knowledge of the disease.

Authors:  Arnd Heiligenhaus; Stephan Thurau; Maren Hennig; Rafael S Grajewski; Gerhild Wildner
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-08-25       Impact factor: 3.117

3.  Bilateral diaphragmatic paralysis associated with the use of the tumor necrosis factor-alpha inhibitor adalimumab.

Authors:  Mina Mecheal Benjamin; Alan William Martin; Randall Lee Rosenblatt
Journal:  Proc (Bayl Univ Med Cent)       Date:  2014-04

4.  Peripheral neuropathy in two patients with rheumatoid arthritis receiving infliximab treatment.

Authors:  Maria G Tektonidou; John Serelis; Fotini N Skopouli
Journal:  Clin Rheumatol       Date:  2006-07-06       Impact factor: 2.980

5.  Infliximab-associated neuropathy in RA patients--the importance of considering the diagnosis of mononeuritis multiplex.

Authors:  J Birnbaum
Journal:  Clin Rheumatol       Date:  2006-10-25       Impact factor: 2.980

6.  A case of spontaneously recovering multifocal motor neuropathy with conduction blocks (MMNCB) during anti-TNF alpha therapy for ankylosing spondylitis.

Authors:  Giuseppe Paolazzi; Susanna Peccatori; Francesco P Cavatorta; Alberto Morini
Journal:  Clin Rheumatol       Date:  2009-04-07       Impact factor: 2.980

7.  Investigation of effects of two-different treatment modalities on nerve conduction in patients with ankylosing spondylitis.

Authors:  Erhan Capkin; Murat Karkucak; Muammer Muslim Kose; Vildan Altunayoğlu Çakmak; Aysegul Kucukali Turkyilmaz; Mehmet Tosun
Journal:  Rheumatol Int       Date:  2010-12-01       Impact factor: 2.631

Review 8.  Monoclonal antibody therapy-associated neurological disorders.

Authors:  Xavier Bosch; Albert Saiz; Manuel Ramos-Casals
Journal:  Nat Rev Neurol       Date:  2011-01-25       Impact factor: 42.937

Review 9.  Update on medication-induced peripheral neuropathy.

Authors:  Louis H Weimer; Noor Sachdev
Journal:  Curr Neurol Neurosci Rep       Date:  2009-01       Impact factor: 5.081

Review 10.  Status of immune mediators in painful neuropathies.

Authors:  Nurcan Uçeyler; Claudia Sommer
Journal:  Curr Pain Headache Rep       Date:  2008-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.